(Q24186037)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6486283&resulttype=core&format=json

14 May 2020

main subject

arterial hypertension

1 reference

Heidi N Boyda

2

Heidi N

Boyda

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6486283&resulttype=core&format=json

14 May 2020

James M Wright

series ordinal

3

author given names

James M

author last names

Wright

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6486283&resulttype=core&format=json

14 May 2020

Gavin W K Wong

series ordinal

1

author given names

Gavin W K

author last names

Wong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6486283&resulttype=core&format=json

Cochrane Database of Systematic Reviews

14 May 2020

language of work or name

1 reference

10 March 2016

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6486283&resulttype=core&format=json

14 May 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6486283&resulttype=core&format=json

14 May 2020

page(s)

CD007451

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6486283&resulttype=core&format=json

Antihypertensive effect of doxazosin in hypertensive patients: comparison with atenolol

14 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Atenolol and chlorthalidone in combination for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Bisoprolol and Hypertension: Effects on Sexual Functioning in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Antihypertensive and Metabolic Effects of Single and Combined Atenolol Regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Double-blind, placebo-controlled crossover comparison of five classes of antihypertensive drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Influence of drugs and gender on the arterial pulse wave and natriuretic peptide secretion in untreated patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

A comparison of atenolol and nebivolol in isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

A dose-response study of atenolol in mild to moderate hypertension in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

The effect of metoprolol treatment on insulin sensitivity and diurnal plasma hormone levels in hypertensive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Controlled study of atenolol in treatment of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

The effects of clonidine hydrochloride versus atenolol monotherapy on serum lipids, lipid subfractions, and apolipoproteins in mild hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Atenolol once-daily in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Effect of long-term beta-adrenergic-blockade on calf blood flow in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Comparison of once daily atenolol, nitrendipine and their combination in mild to moderate essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Methyldopa and propranolol or practolol in moderate hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Atenolol, sustained-release oxprenolol, and long-acting propranolol in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

The efficacy and tolerability of nebivolol in hypertensive African American patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Trial of atenolol and chlorthalidone for hypertension in black South Africans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Haemodynamic effects of adrenaline during treatment of hypertensive patients with propranolol and metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

A dose-response trial of nebivolol in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Dose-dependent effects of betaxolol in hypertension: a double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Blood pressure lowering efficacy of beta-blockers as second-line therapy for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Calcium channel blockers versus other classes of drugs for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Blood pressure lowering efficacy of angiotensin receptor blockers for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Oral beta-blockers for mild to moderate hypertension during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Blood pressure lowering efficacy of renin inhibitors for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Nebivolol: a third-generation beta-adrenergic blocker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Beta-blockers for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

First-line drugs for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Headaches and the Treatment of Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007451.PUB2

Choosing a first-line drug in the management of elevated blood pressure: what is the evidence? 2: Beta-blockers

21 January 2018

1 reference

12 December 2020

The application of nebivolol in essential hypertension: a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT)

1 reference

12 December 2020

Effect of antihypertensive medication on endurance exercise capacity in hypertensive sportsmen

1 reference

12 December 2020

Effect of bisoprolol on blood pressure and arterial hemodynamics in systemic hypertension

1 reference

12 December 2020

Factorial Antihypertensive Study of an Extended-Release Metoprolol and Hydrochlorothiazide Combination

1 reference

12 December 2020

Impact of diagnosis and treatment of hypertension on quality of life: a double-blind, randomized, placebo-controlled, cross-over study of betaxolol

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled parallel-group study to assess the efficacy and safety of nebivolol, a novel beta-blocker, in patients with mild to moderate hypertension.

1 reference

12 December 2020

Comparative effects of enalapril, atenolol and chlorthalidone on blood pressure and kidney function of diabetic patients affected by arterial hypertension and persistent proteinuria

1 reference

12 December 2020

Diltiazem and atenolol in essential hypertension: additivity of effects on blood pressure and cardiac conduction with combination therapy

1 reference

12 December 2020

The efficacy of low dose metoprolol CR/ZOK in mild hypertension and in elderly patients with mild to moderate hypertension

1 reference

12 December 2020

Cardiac and skeletal muscle adaptations to training in systemic hypertension and effect of beta blockade (metoprolol or propranolol)

1 reference

12 December 2020

Pafenolol in hypertension: a double-blind randomized trial of a new beta 1-selective adrenoceptor blocker

1 reference

12 December 2020

Verapamil and nebivolol improve carotid artery distensibility in hypertensive patients.

1 reference

12 December 2020

Enalapril and atenolol in essential hypertension: attenuation of hypotensive effects in combination

1 reference

12 December 2020

Duration of the antihypertensive action of atenolol, enalapril and placebo: a randomized within-patient study using ambulatory blood pressure monitoring

1 reference

12 December 2020

Haemodynamic and metabolic responses to prolonged exercise after chronic beta 1-adrenoceptor blockade in hypertensive man

1 reference

12 December 2020

A comparison of celiprolol and atenolol in the treatment of hypertension: a placebo controlled double blind study

1 reference

12 December 2020

Dose response studies of bevantolol in hypertensive patients

1 reference

12 December 2020

The Effect of Metoprolol -a New Selective Adrenergic β1-receptor Blocking Agent-in Mild Hypertension

1 reference

12 December 2020

Atenolol vs. amiloride-hydrochlorothiazide in the treatment of mild to moderate hypertension: a double-blind, crossover, placebo-controlled study

1 reference

12 December 2020

Atenolol as primary therapy in previously untreated hypertensives and as an adjuvant to other therapy. A South African Multicentre Study

1 reference

12 December 2020

Lower limb haemodynamics during antihypertensive treatment with metoprolol and propranolol.

1 reference

12 December 2020

The relative antihypertensive potency of propranolol, oxprenolol, atenolol, and metoprolol given once daily. A double-blind, crossover, placebo-controlled study in ambulatory patients

1 reference

12 December 2020

Monitoring 24-hour blood pressure in a drug trial. Evaluation of a noninvasive device

1 reference

12 December 2020

Systolic time intervals as possible predictors of pressure response to sustained beta-adrenergic blockade in arterial hypertension. A within-patient, placebo-controlled study

1 reference

12 December 2020

Effects of atenolol and hydrochlorothiazide on blood pressure and plasma catecholamines in essential hypertension

1 reference

12 December 2020

Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life

1 reference

12 December 2020

First-line therapy option with low-dose bisoprolol fumarate and low-dose hydrochlorothiazide in patients with stage I and stage II systemic hypertension

1 reference

12 December 2020

Bisoprolol, a once-a-day beta-blocking agent for patients with mild to moderate hypertension

1 reference

12 December 2020

Sexual sequelae of antihypertensive drugs: treatment effects on self-report and physiological measures in middle-aged male hypertensives

1 reference

12 December 2020

Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients

1 reference

12 December 2020

Haemodynamic effects and pharmacokinetics of oral d- and l-nebivolol in hypertensive patients

1 reference

12 December 2020

Nebivolol vs atenolol and placebo in essential hypertension: a double-blind randomised trial

1 reference

12 December 2020

10.1002/14651858.CD007451.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6486283&resulttype=core&format=json

release_psk7na5mezdttdctipdy32thti

14 May 2020

Fatcat ID

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6486283&resulttype=core&format=json

14 May 2020

PubMed publication ID

26961574

1 reference